JP2006522797A5 - - Google Patents

Download PDF

Info

Publication number
JP2006522797A5
JP2006522797A5 JP2006506512A JP2006506512A JP2006522797A5 JP 2006522797 A5 JP2006522797 A5 JP 2006522797A5 JP 2006506512 A JP2006506512 A JP 2006506512A JP 2006506512 A JP2006506512 A JP 2006506512A JP 2006522797 A5 JP2006522797 A5 JP 2006522797A5
Authority
JP
Japan
Prior art keywords
aza
bicyclo
phenyl
ylmethyl
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006506512A
Other languages
English (en)
Japanese (ja)
Other versions
JP4493648B2 (ja
JP2006522797A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2004/001237 external-priority patent/WO2004089909A1/en
Publication of JP2006522797A publication Critical patent/JP2006522797A/ja
Publication of JP2006522797A5 publication Critical patent/JP2006522797A5/ja
Application granted granted Critical
Publication of JP4493648B2 publication Critical patent/JP4493648B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006506512A 2003-04-14 2004-04-02 オピオイド受容体拮抗薬としての2‐アザビシクロ(3.3.1)ノナン誘導体 Expired - Fee Related JP4493648B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46260503P 2003-04-14 2003-04-14
PCT/IB2004/001237 WO2004089909A1 (en) 2003-04-14 2004-04-02 2-azabicyclo[3.3.1]nonane derivatives as opioid receptor antagonists

Publications (3)

Publication Number Publication Date
JP2006522797A JP2006522797A (ja) 2006-10-05
JP2006522797A5 true JP2006522797A5 (https=) 2007-03-22
JP4493648B2 JP4493648B2 (ja) 2010-06-30

Family

ID=33159854

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006506512A Expired - Fee Related JP4493648B2 (ja) 2003-04-14 2004-04-02 オピオイド受容体拮抗薬としての2‐アザビシクロ(3.3.1)ノナン誘導体

Country Status (11)

Country Link
US (2) US7056930B2 (https=)
EP (1) EP1615893B1 (https=)
JP (1) JP4493648B2 (https=)
AT (1) ATE449074T1 (https=)
BR (1) BRPI0409369A (https=)
CA (1) CA2522180C (https=)
DE (1) DE602004024188D1 (https=)
DK (1) DK1615893T3 (https=)
ES (1) ES2334570T3 (https=)
MX (1) MXPA05011060A (https=)
WO (1) WO2004089909A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006708B1 (ru) * 2001-10-22 2006-02-24 Пфайзер Продактс Инк. Производные 3-азабицикло (3.1.0) гексана в качестве антагонистов опиоидного рецептора
EP1615894A2 (en) * 2003-04-14 2006-01-18 Pfizer Products Inc. 3-azabicyclo 3.2.1 octane derivatives
US20050043345A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI409067B (zh) 2007-02-28 2013-09-21 Theravance Inc 8-氮雜雙環〔3.2.1〕辛烷化合物之結晶型
TWI425945B (zh) * 2007-05-28 2014-02-11 Seldar Pharma Inc 四氫異喹啉-1-酮衍生物或其鹽
TWI423801B (zh) * 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之8-氮雜雙環〔3.2.1〕辛基-2-羥基苯甲醯胺化合物
ATE502939T1 (de) * 2007-08-27 2011-04-15 Theravance Inc Disubstituierte alkyl-8-azabicycloä3.2.1üoktan- verbindungen als mu-opioid-rezeptorantagonisten
ES2390195T3 (es) * 2007-08-27 2012-11-07 Theravance, Inc. Compuestos de amidoalquil-8-azabiciclo(3,2,1)octano, como antagonistas del receptor opioide mu
EP2195313B1 (en) * 2007-08-27 2014-04-02 Theravance, Inc. Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
GB0721178D0 (en) * 2007-10-29 2007-12-05 Glaxo Group Ltd Chemical compounds
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
CN105764888B (zh) * 2013-11-20 2018-04-06 株式会社三和化学研究所 一种新的3‑氮杂双环[3.1.0]己烷衍生物以及其医药用途
CN107428687B (zh) * 2015-05-20 2021-06-11 宇部兴产株式会社 一种3-氮杂双环[3.1.0]己烷衍生物的盐的晶体以及其医药应用
US20190308987A1 (en) * 2016-06-02 2019-10-10 Virginia Commonwealth University Dual modulators of both mu and kappa opioid receptors
SG11202007422QA (en) 2018-02-05 2020-09-29 Alkermes Inc Compounds for the treatment of pain
WO2019182950A1 (en) * 2018-03-19 2019-09-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Biased potent opioid-like agonists as improved medications to treat chronic and acute pain and methods of using the same
KR102266854B1 (ko) * 2019-11-06 2021-06-18 계명대학교 산학협력단 마약 중독 예방 또는 치료용 약학조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2143145A (en) * 1934-11-06 1939-01-10 Farnsworth Television Inc Projection means
US6559159B2 (en) * 2001-02-01 2003-05-06 Research Triangle Institute Kappa opioid receptor ligands

Similar Documents

Publication Publication Date Title
JP2006522797A5 (https=)
RU2470910C2 (ru) Соединения, представляющие собой алкинилфенильные производные, для лечения офтальмических заболеваний и расстройств
RU2437877C2 (ru) Новые производные тиофена в качестве агонистов рецептора s1p1/edg1
JP2009523165A5 (https=)
JP2005508293A5 (https=)
CA2418652C (en) Novel 3-substituted urea derivatives and medicinal use thereof
JP2006524222A5 (https=)
JP2020527175A5 (https=)
JP2016509591A (ja) Hbv感染に対する新規抗ウイルス剤
JP2005511508A5 (https=)
JP2006522035A5 (https=)
JP2004525117A5 (https=)
JP2006521359A5 (https=)
PT823896E (pt) Oximas hidrazonas e olefinas substituidas como antagonistas de neuroquinina
HUP0101793A2 (hu) Antranilsav-származékok, mint cGMP-foszfodiészteráz gátlók
JP2023052027A5 (https=)
JPH10279578A5 (https=)
JP2013506637A5 (https=)
JP2009535426A5 (https=)
JP2009543794A5 (https=)
JP2006522795A5 (https=)
JP2008542365A5 (https=)
JP2009520791A5 (https=)
JP2020508300A5 (https=)
CN1053665C (zh) 新的二芳基取代的1,3-氧硫杂-、1,3-二硫杂-和1,3-二氧杂戊环衍生物